In this episode, we interview Dr. Emily Leproust, CEO and co-founder of Twist Bioscience, a leading and rapidly growing synthetic biology and genomics company that is well-known for its disruptive DNA synthesis platform. We talk to Dr. Leproust about the future of DNA synthesis, making cloning obsolete, and eating challenges for breakfast.
This episode was recorded in September 2021. During the interview, Emily mentions the publication of an article "last week" that happened in September of 2021. You can find this article here.
For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!